Systematic review with meta-analysis: The prevalence, risk factors and outcomes of upper gastrointestinal tract crohn's disease

Author(s):  
Yip Han Chin ◽  
Cheng Han Ng ◽  
Snow Yunni Lin ◽  
Sneha Rajiv Jain ◽  
Gwyneth Kong ◽  
...  
2018 ◽  
Vol 12 (12) ◽  
pp. 1399-1409 ◽  
Author(s):  
Thomas Greuter ◽  
Alberto Piller ◽  
Nicolas Fournier ◽  
Ekaterina Safroneeva ◽  
Alex Straumann ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Soorya N. Aggarwal ◽  
Yana Cavanagh ◽  
Lan Wang ◽  
Amer Akmal ◽  
Matthew A. Grossman

Upper gastrointestinal tract predominant Crohn’s Disease (CD) remains an elusive clinical entity, manifesting limited or vague symptomatology, eluding clinical suspicion, and delaying subsequent diagnostic evaluation. As a result, it has not been widely described and there is a lack of clear recommendations for diagnosis or management. Standard IBD evaluation including serologic testing, imaging, and endoscopy may initially not be fruitful. Furthermore, endoscopic evaluation may be grossly normal in patients without long standing-disease. We describe an 18-year-old male who presented with only unexplained, persistent iron-deficiency anemia. Extensive outpatient testing including multiple endoscopic evaluations with standard biopsies was unfruitful. Ultimately, a positive fecal calprotectin prompted enteroscopy with endoscopic mucosal resection (EMR) in an effort to obtain a larger, deeper tissue specimen. Grossly cobblestoned mucosa along with histopathology revealing focal crypt abscesses, chronic inflammation in the lamina propria, and superficial foveolar epithelial regenerative changes were consistent with CD. This patient’s case illustrates the need for a high degree of suspicion for CD in patients with unexplained or persistent iron deficiency anemias. Persistent investigation yielded an elevation in fecal calprotectin suggesting underlying gastrointestinal inflammation and prompted advanced endoscopic evaluation with EMR. Waxing and waning tissue findings are characteristic of CD and pose a unique challenge in patients with upper gastrointestinal predominant pathology. As such, diligent workup including laboratory evaluation, imaging, and serial endoscopy is critical to establish pathology and dictate subsequent management in IBD, especially upper gastrointestinal tract predominant CD.


2009 ◽  
Vol 10 (2) ◽  
pp. AB19
Author(s):  
N. Chouqi ◽  
F. Ajana ◽  
I. Benelbarhdadi ◽  
A. Timraz ◽  
W. Essamri ◽  
...  

Endoscopy ◽  
1993 ◽  
Vol 25 (04) ◽  
pp. 282-286 ◽  
Author(s):  
M. Alcántara ◽  
R. Rodriguez ◽  
J. L. M. Potenciano ◽  
J. L. Carrobles ◽  
C. Muñoz ◽  
...  

2019 ◽  
Vol 64 (11) ◽  
pp. 3291-3299 ◽  
Author(s):  
Xiao-Wei Sun ◽  
Juan Wei ◽  
Zhao Yang ◽  
Xin-Xin Jin ◽  
Hai-Jun Wan ◽  
...  

2012 ◽  
Vol 142 (5) ◽  
pp. S-779
Author(s):  
William J. Tremaine ◽  
William A. Faubion ◽  
Darrell S. Pardi ◽  
Lawrence J. Timmons ◽  
Sunanda V. Kane ◽  
...  

1990 ◽  
Vol 4 (1) ◽  
pp. 26-32 ◽  
Author(s):  
Hugh J Freeman

Crohn's disease may involve any site within the gastrointestinal tract. Usually pathology is present in the ileum and/or colon, but atypical presentations may occur with apparently 'isolated' involvement of the oropharynx, esophagus or gastroduodenum. If changes typical of Crohn's disease are detected in the upper gastrointestinal tract, then a careful assessment is required involving radiographic, endoscopic and histologic studies to determine if pathology is present in more distal intestine. In addition , microbiologic studies may be important to exclude infectious causes, especially of granulomas. If these studies are negative, prolonged follow-up may be required to establish a diagnosis of Crohn's disease. Although upper gastrointestinal involvement is increasingly recognized as a significant cause of morbidity in Crohn's disease, the treatment options are limited , largely anecdotal and need to be the subject of detailed epidemiologic investigation and clinical trials.


Sign in / Sign up

Export Citation Format

Share Document